During the perioperative period, the operation type and duration were noted. Moreover, after the operation had been performed, the investigators documented from the drug charts the type and dose of analgesics used on the day of operation.
On the 1st, 3rd, and 5th postoperative days, all patients were asked about the following: their VAS score at the initial visit, the pain character, if they had informed the staff about the pain, and whether they received adequate treatment after they had informed the staff. The patient was asked if they had received analgesic medication in the last 6 hours prior to the visit, and the kind of treatment was noted from the drug charts.
Some additional questions were asked. On the 1st postoperative day, the patient was asked to determine the maximal VAS score on the day of surgery and at what time this pain occurred. 1 On the 5th postoperative day, the medical staff was asked if any surgery-related complications (wound infection, reoperation, a second procedure, or a postoperative bleeding) occurred in any of the study patients.
With the visit on the 5th postoperative day, the period of observation ended. All enrolled patients were admitted to hospital until at least the 5th postoperative day. Participation in this study did not delay discharge from the hospital. The discharge decisions were made by the neurosurgeons only. It was current practice during the entire study period that patients undergoing lumbar flavectomy, for example, were hospitalized for at least 1 week postoperatively. Similarly, in the group of patients undergoing miscellaneous extremity procedures (for example, neurolysis of the median nerve), only two of the nine patients were monitored until postoperative Day 5. A patient was excluded from the study if still intubated 24 hours after surgery, if not aware enough to answer questions, or if unwilling to cooperate further, for any other reason.
Statistical Analysis
To analyze the data, the patients were grouped by surgical procedure. Each separate study group required 10 or more patients. There were 10 different procedures with 10 or more patients per group: TTR, VPS placement, TSO, SBICPM, THR, ACS, CS, LF, laminectomy, and LTR. One hundred nine patients underwent procedures that were performed fewer than 10 times (for example, lumbar fixation or frontobasal covering); these patients were divided into three groups: MSPs, MCPs, and MEXPs.
The results of the preoperative interviews were analyzed if the patient was excluded on or after the 1st postoperative day. If a patient had to undergo reoperation for a surgery-related complication, the results obtained before the complication were still analyzed. The VAS scores and findings of the second operation were analyzed as if the data were obtained in a new case.
Intergroup comparisons for age, weight, operative time, maximal anticipated VAS score, maximal VAS score, and VAS score on the 1st, 3rd, and 5th postoperative days were conducted using an ANOVA with a Bonferroni posttest or a nonparametric Kruskal-Wallis test when appropriate. Intergroup comparisons for ASA class distribution and male/ female ratios were analyzed with the chi-square test for independence. Intragroup comparisons of VAS scores over time were made using a repeated-measures ANOVA with a Bonferroni posttest or a Friedman nonparametric test when appropriate. A Student t-test was used to demonstrate a significant difference between the maximal anticipated VAS score and the maximal real postoperative VAS score.
Visual analog scale scores were stratified according to several characteristics: 1) age range (0-19, 20-39, 40-59, and Ն 60 years); 2) sex; 3) ASA classification; 4) pain character over time, within the different treatment groups; 5) different types of postoperative pain medication (patients receiving no pain medication; those receiving WHO Class I, II, or III pain medication; 31, 32 or different types of pain medication), within the different study groups; 6) whether patients asked for pain medication after surgery, within the different study groups; 7) whether patients received adequate treatment after informing the personnel about pain, within the different study groups; 8) a complicated compared with an uncomplicated postoperative course; and 9) whether patients had pain before surgery. Table 1 provides a summary of WHO classes of pain medication.
Intergroup comparisons of VAS intensity scores were analyzed using an ANOVA with a Bonferroni posttest, a nonparametric Kruskal-Wallis test, or a t-test, as appropriate. Differences in patient numbers and pain character (distribution) within groups, after stratification, were analyzed using a chi-square test for independence. Intragroup VAS scores over time, measured after stratification, were compared using a repeated-measures ANOVA with a Bonferroni posttest or a Friedman nonparametric test, as appropriate. Statistical significance was accepted at a probability value less than 0.05.
Results
Clinical and surgical data are summarized in Table 2 ; significant intergroup differences are indicated. Table 3 illustrates the VAS scores in the different study groups over time; significant differences between groups and over time are indicated. The maximal VAS score was significantly higher than the maximal anticipated VAS score overall and in the TSO, SBICPM, THR, LF, MSP, and MCP groups.
The distribution in pain character over time, with different operation types, is shown in Table 4 ; significant differences in pain distribution and VAS scores for the different pain categories are indicated. Table 5 illustrates data pertaining to patients who did and who did not ask for analgesic medication; significant differences are indicated. Table 6 provides a summary of data pertaining to patients who did and did not feel the relief of pain was adequate after receiving analgesic medication, with significant intergroup differences indicated.
On the 1st postoperative day, the VAS scores were significantly lower among patients receiving WHO Class I medication than those receiving WHO Class II medication overall and in the CS and LF groups; however, the scores were lower than those in patients receiving WHO Class III medication overall. On the 1st postoperative day the VAS score was significantly lower in patients receiving WHO Class III medication than in those receiving Class II medication in the LF group. On the 3rd postoperative day, the VAS score was significantly lower in patients receiving WHO Class I medication than in those receiving WHO Class II medication overall and in those in the LF group, and lower than those in patients receiving WHO Class III medication in the overall population. Finally, on the 5th postoperative day, the VAS score was significantly lower in patients receiving WHO Class I medication compared with WHO Class II medication overall and in the CS and LF groups; they were also lower than in patients receiving WHO Class III medication overall and in the LF group.
In the overall patient population, the VAS scores on the 1st, 3rd, and 5th postoperative days were significantly lower in patients without preoperative pain (16.6 Ϯ 19.7; 10.2 Ϯ 14.9; and 6.1 Ϯ 12.9, respectively) than in patients with preoperative pain (28.1 Ϯ 21.8; 20.7 Ϯ 21.4; and 15.0 Ϯ 18.0, respectively). The pain character was also significantly different between patients with and without preoperative pain. Patients with pain before surgery experienced significantly more sharp and referred pain after surgery (on Days 1, 3, and 5). Patients without pain before surgery more often reported "no pain" during the postoperative period (on Days 1, 3, and 5). Additionally, the VAS scores were significantly lower in patients without presurgical pain than in those with pain before surgery on Days 1, 3, and 5 in patients in the TTR and MSP groups; on Day 1 for those in the TSO group; on Days 3 and 5 for those in the LF group; and on Day 5 for those in the VPS placement, SBICPM, THR, and LTR groups.
The VAS score was independent of sex. On the 5th postoperative day, patients with ASA Class III morbidities suffered significantly more pain than those with ASA Class I morbidities. The preoperative VAS score was significantly higher in patients in the 40 to 59-year-old age group than in those 0 to 19 years of age. The maximal postoperative VAS score was significantly higher in patients in the 20 to 39-year-old age group than in those greater than 60 years of age.
Overall, 36 patients sustained relevant surgery-related complications such as delayed wound healing (one case), meningitis (two cases), fluid-filled fistula (three cases), early VPS-related problems (three cases), and early relapse of lumbar hernia (10 cases). Seventeen patients had to undergo a reoperation during the study period (one each in the THR, ACS, and MSP groups; four in the CS group; and 10 in the LF group).
In the overall patient population, the VAS scores were significantly higher on the 3rd and 5th postoperative days in patients with surgical complications (30. Discussion Not surprisingly, in the different surgical groups, VAS scores decreased significantly over time after surgery. More interestingly, the patients in the TTR group had significantly less pain on the day of operation and on postoperative Days 1, 3, and 5 than those in the other groups (except for the SBICPM group), and this was significantly different from groups CS and LF. This finding is supported by another study in which investigators found that craniotomy procedures were associated with lesser analgesic requirements than extracranial procedures. 10 Some patients undergoing trephination, however, do suffer serious postoperative pain. 22 In those patients, codeine phosphate has been shown to be more effective than tramadol. 4 Scalp nerve blocks can decrease the pain severity after craniotomy, and this effect is long lasting, possibly due to a preemptive mechanism. 20 In patients undergoing craniotomy, postoperative pain is treated insufficiently with acetaminophen alone and should be combined with tramadol or nalbuphine. 30 In contrast to the general accepted clinical impression that craniotomy is associated with less perioperative pain, De Benedittis and coworkers 8 have indicated that postoperative pain in patients undergoing craniotomy is an important and neglected clinical problem that, to provide better and more appropriate treatment, deserves greater attention by surgical teams. In our study, in the preoperative phase, the patients in the TTR group asked for analgesic agents less frequently than those in the other groups. Most patients in this group did not receive any analgesic medication before surgery (150 cases), although a few did (six cases). Also in the postoperative phase, the mean VAS scores in the TTR group were lower than those in the other groups, except for the SBICPM group. Directly after surgery, 99 of the 145 patients undergoing TTR required no analgesic agents. On Days 1, 3, and 5 after surgery, only 38 of 145, 21 of 141, and 20 of 140 patients, respectively, needed analgesic medication. When these patients needed analgesic relief, more than 60% of them used WHO Class II medication, a finding in agreement with data published in the current literature. There were no significant differences in VAS scores in the patients receiving different WHO class medications. Based on these data, we conclude that for patients undergoing trephination, on-demand analgesic treatment seems justified.
Compared with the TTR group, patients undergoing neurosurgical spinal procedures experience a different perioperative course in terms of pain character and pain intensity. Patients in the CS and LF groups suffered more pain before surgery than those in the TTR and VPS placement groups. Interestingly, however, all patients in the different groups expected to have the same amount of postoperative pain, despite their varying preoperative pain scores. Moreover, the maximal anticipated VAS score was lower than the actual maximal VAS score in the following groups: TSO, SBICPM, THR, ACS, CS, LF, laminectomy, MSP, and MCP. This leads us to conclude that the anticipated maximal VAS score is independent of the neurosurgical procedure or the extent of preoperative pain and that postoperative pain in patients who have undergone a neurosurgical procedure is greater than anticipated. However, anticipated pain might be influenced by preoperative teaching. In our study, we did not take this into account. When visited by the examiner preoperatively, only approximately one half of the patients were informed by the surgeon. Additional studies may be undertaken to evaluate the impact of adequate preoperative teaching about pain management options on postoperative pain and patient satisfaction. Referred pain can be described as a radicular pain with a possible projecting and/or neuropathic component. Because this pain is difficult to treat with opioid agents, the use of anticonvulsant and antidepressive drugs should be seriously considered. The mean VAS score in patients with referred pain was significantly higher than that in patients with local pain in the LF group on the 3rd and 5th postoperative days, whereas in patients undergoing TTR and VPS placement normal headache was more painful than local pain, as measured on the 5th relative to the 3rd postoperative day. These findings underscore that the pain character can direct the physician to the patients who are expected to suffer the most intense postoperative pain. In addition, in the CS and LF groups there was a shift from preoperative referred pain to local pain postoperatively. This finding suggests that after spinal surgery nerve decompression decreases the extent of referred pain and the pain originates in the operative wound, resulting in local pain; however, some patients still suffered from referred pain after surgery. These patients experienced greater pain than those with other pain characteristics, which suggests that patients with referred pain after CS and LF require more intensive pain management than do those with local pain.
During the entire observation period in the CS and LF groups, there was significantly more referred pain than in the other groups. The following factors have been found to be predictive of surgical outcome after lumbar disc surgery: prolonged current pain attack, report of long-term illness, anxiety, severe pain reported immediately after surgery, employment status, and the presence of complete herniation at surgery. 25 The authors of another study also found a predictive value for the outcome after anterior cervical decompression; 21 the main value by which to predict postoperative pain intensity was the magnitude of the preoperative kyphosis. In our study, age, ASA class, and sex were not predictive of pain character, pain intensity, or the need for reoperation in any treatment group. Overall, however, the mean VAS score for patients with a postsurgical complication was significantly higher than that for patients without complications. This finding may suggest that clinicians should be mindful of patients with extremely high VAS scores because postoperative complications may occur. We realize, however, that patients who experience surgery-related complications may have anxiety or other factors that could influence the VAS score. We are also aware of the fact that in patients who must undergo a second procedure, some tolerance or tachyphylaxia to the analgesic medication used may have developed. This might bias the results. Ours, however, was an observational study reflecting daily clinical routine; thus, the number of patients undergoing a second procedure during the study period was small. The impact of a reoperation on pain medication requirements may well be the subject of another study.
Analysis of our results shows that patients with preoperative pain suffer significantly more postoperative pain than patients without preoperative pain. In another study investigators also found that patients with preoperative pain suffer more pain postoperatively; 14 however, they investigated all surgical procedures except heart and intracranial neurosur-gical procedures. Using a scoring system to assess quality of recovery after cranial and spinal surgery, one group has reported that postoperative pain and neurological deficits correlated with poor postoperative recovery. 17 Evaluation of our data also suggests that neurosurgical patients who suffer preoperative pain require more intensive pain management after surgery than patients without preoperative pain. Age, sex, expected incision size, and surgical procedure have also been shown to affect the postoperative pain intensity. 14 We found no significant difference between males and females in terms of pain intensity, but we did find a correlation with age. Whereas there was a trend toward higher preoperative VAS scores in older patients, there was likewise a trend toward higher postoperative VAS scores in younger patients. Therefore, in young patients the increase in pain during the entire observation period was greater than that in old patients. Moreover, patients with ASA Class III morbidity had significantly more pain than those with ASA Class I morbidity on the 5th postoperative day; however, this was an isolated finding, and it may be too early to draw any conclusions from it.
The mean VAS score for patients who asked for medication was significantly higher than the VAS score for those who did not ask for medication. On Days 1 and 3, patients in the ACS group asked for pain medication significantly more often than those in the other groups; however, we assumed that this group was adequately treated with the given pain medication because, during the observation period, significantly increased VAS scores were not documented in these patients. It has been reported that patients are not afraid to ask for analgesic drugs 6 and that nurses underestimate postoperative pain intensity of patients. 11 Moreover, there are indications that individual pain assessment is poorly documented and that a nurse's record of a patient's postoperative pain experience differed from the patient's self-assessment. 5 Analysis of our data showed that in pa-
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Pain in neurosurgically treated patients (99) 190 (99) 12 (100) 10 (100) 55 (100) 45 (10) 8 (89) 79 (99) 187 (97) 12 (100) 10 (100) 53 (96) 42 (93) 7 (78) 75 (94) 184 (96) 12 (100) 10 (100) 48 (87) 33 (73) 2 (22) 23 (29) 57 (30) 2 (17) 1 (10) 10 (18) 9 (20) 2 (25) 45 (57) 88 (46) 8 (67) 6 (60) 25 (45) 19 (42) 4 (50) 12 (15) 46 (24) 1 (8) 3 (30) 20 (36) 14 (31) 2 (25) tients who asked for pain medication VAS scores were significantly higher and the patients needed to be treated accordingly. The mean VAS score in patients who felt they had not been adequately treated was significantly higher than that in patients who felt they had received adequate treatment. This finding suggests that the VAS score is not only useful for estimating pain intensity but can also be used to review current pain management protocols.
In patients who underwent CS and LF and who received WHO Class I medication, the mean VAS score was significantly lower during the postoperative period than that in patients receiving WHO Class II medication, whereas the mean VAS score in patients receiving WHO Class III medication was lower again. This leads us to conclude that in a subgroup of patients undergoing CS or LF and who do not benefit from WHO Class I medication alone, WHO Class II medication is also insufficient, and the patient should be treated with WHO Class III medication directly.
One limitation of the present study may have been that we did not separate the different opioid agents used intraoperatively; however, the anesthesiologists were not involved in the study, and the use of opioid agents was left to their discretion. Thus, the results of this observational study reflect a clinical routine. Older patients reported greater pain before surgery than younger patients whereas younger patients reported more pain after surgery than older patients. The postoperative recovery takes longer in patients with serious comorbidity compared with a faster recovery in otherwise healthy patients. The anticipated pain intensity is independent of the operation type or the preoperative pain intensity perceived.
Conclusions
Based on our findings, we can conclude that neurosurgical procedures are more painful than anticipated by the patient. The idea that pain associated with neurosurgical procedures is insufficiently managed was recently addressed in an editorial titled, "Postcraniotomy pain remains a real headache!" 28 However, considering the high number of patients without postoperative pain, patients undergoing craniotomy can be treated with on-demand analgesic medication, but only if the nurses on the ward react promptly. Therefore, patient-controlled analgesia may be an effective and safe option. 23 Recently, a detailed review on acute and chronic postcraniotomy pain was published; the authors addressed the different modes of pain treatment after craniotomy and the causative factors for the development of chronic postcraniotomy pain. 9 Patients undergoing all other types of neurosurgical procedures should receive scheduled treatment of analgesic drugs at least on the 1st postoperative day. Patients undergoing spinal surgery need intensive pain treatment in the preoperative phase; in these patients, a shift in pain character from referred pain preoperatively to local pain postoperatively is expected. A referred pain character after LF can direct the physician to those patients expected to suffer the most intense pain. In patients with preoperative pain, postoperative pain is more intense than in those without pain before surgery, and clinicians must undertake more intensive pain management in the patients after surgery. Patients who ask for analgesics or those who claim to be undertreated need to be taken seriously and treated accordingly. Receiving more pain treatment does not always lead to lower pain scores. Increased analgesic intake might still not be enough for some patients. It should be anticipated in patients with increased postoperative VAS scores that surgery-related complications will occur. In patients undergoing spinal surgery, there is a subset that does not benefit from WHO Class I medication alone, and WHO Class III medication should be provided directly. In summary, we have shown the importance of pain and its sufficient treatment after neurosurgical procedures in an observational study setting. At present, pain is considered to be the "fifth vital sign." 16 Patients and regulatory agencies (for example, the Joint Commission on Accreditation of Healthcare Organizations) are paying much more attention to the appropriate and timely treatment of pain. It is our hope that the findings of this study will be used by neurosurgeons and neuroanesthesiologists as a reference for future studies in an effort to optimize pain management after neurosurgical procedures.
